(Q43694310)

25 November 2017

Cost effectiveness of intradermal vs. subcutaneous hepatitis b vaccination for the mentally handicapped (English)

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

5 December 2022

0 references

J. Hayashi

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832182

5 December 2022

K. Nakashima

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832182

5 December 2022

A. Noguchi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832182

5 December 2022

M. Morofuji

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832182

5 December 2022

S. Kashiwagi

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1832182

5 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1832182

5 December 2022

publication date

1 July 1991

1 reference

full work available at URL

25 November 2017

https://api.elsevier.com/content/article/PII:016344539194019G?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

https://api.elsevier.com/content/article/PII:016344539194019G?httpAccept=text/plain

5 December 2022

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

5 December 2022

1 reference

25 November 2017

23

1 reference

25 November 2017

1

1 reference

25 November 2017

39-45

1 reference

Prevalence of hepatitis B infection among residents of an institution for the mentally retarded

25 November 2017

1

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Survey of hepatitis B viral markers at a public day school and a residential institution sharing mentally handicapped students

5 December 2022

2

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Clinical Evaluation in Healthy Adults of a Hepatitis B Vaccine Made by Recombinant DNA

5 December 2022

4

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Comparison of results of recombinant and plasma-derived hepatitis B vaccines in Japanese nursery-school children

5 December 2022

5

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Development of DTH skin reaction to HBsAg in individuals immunized with HB vaccine

5 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Reversal by intradermal hepatitis B vaccination of unresponsiveness to HBsAg

5 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Intradermal hepatitis B vaccination for mentally retarded patients

5 December 2022

8

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Expression of hepatitis B surface antigen gene in yeast

5 December 2022

9

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

An epidemiologic study of hepatitis B virus in Okinawa and Kyushu, Japan

5 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Hepatitis B Vaccination in Down's Syndrome and Other Mentally Retarded Patients

5 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Intradermal vaccination against hepatitis B virus infection in an endemic area (Nigeria), two year results

5 December 2022

15

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Low dose intradermal vaccination against hepatitis B in mentally retarded patients

5 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Safety and immunogenicity of a recombinant hepatitis B vaccine

5 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

Safety and immunogenicity of a purified hepatitis B virus vaccine prepared by using recombinant DNA technology

5 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/0163-4453(91)94019-G

5 December 2022

Identifiers

1 reference

25 November 2017

1 reference